SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/9586EF7BFD4194C7692F31924A185DB06E8DA16FC8F89DB87E011F090606562FB9AD9B3851ED5570A37052CFFEB4C99E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/9586EF7BFD4194C7692F31924A185DB06E8DA16FC8F89DB87E011F090606562FB9AD9B3851ED5570A37052CFFEB4C99E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/9586EF7BFD4194C7692F31924A185DB06E8DA16FC8F89DB87E011F090606562FB9AD9B3851ED5570A37052CFFEB4C99E
http://www.w3.org/2000/01/rdf-schema#comment
"alpha-Internexin was expressed in 53% of 350 pancreatic neuroendocrine tumors. Reduced expression of alpha-internexin was significantly associated with advanced stage metastases recurrence and shorter overall survival."
xsd:string
http://purl.uniprot.org/uniprot/#_5389691CD8CB70A9FD11719B68B7CD8D7AFC2C9CBE394C5251479173FA3F45ECCA810B7F6F2F21C3E9719AFBC78A69AE
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/9586EF7BFD4194C7692F31924A185DB06E8DA16FC8F89DB87E011F090606562FB9AD9B3851ED5570A37052CFFEB4C99E
http://purl.uniprot.org/uniprot/Q16352
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/9586EF7BFD4194C7692F31924A185DB06E8DA16FC8F89DB87E011F090606562FB9AD9B3851ED5570A37052CFFEB4C99E
http://purl.uniprot.org/uniprot/#_Q16352-mappedCitation-24483152
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/9586EF7BFD4194C7692F31924A185DB06E8DA16FC8F89DB87E011F090606562FB9AD9B3851ED5570A37052CFFEB4C99E